SLC5A5 and neoplasm: The use of NIS-directed oncolytic virotherapy methods is primarily because most tumors either do not express NIS themselves or express it in a therapeutically insignificant amount, or because NIS expression is non-functional because the symporter is not incorporated into the tumor cell plasma membrane and, therefore, is unable to capture radioiodine [9,10].